Sleep Apnea Devices Market

Sleep Apnea Devices Market by Type,Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces,Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) - Global Forecasts to 2026

Report Code: MD 1181 Aug, 2021, by marketsandmarkets.com

[325 Pages Report] The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market.

Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls may restrict market growth to a certain extent. The sleep apnea devices market is segmented based on type, end user and region.

Sleep Apnea Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the sleep apnea devices market

The growth of the sleep apnea devices market has massively increased due to the sudden outbreak of the COVID-19 pandemic. In the first quarter of 2020, companies faced certain operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and the adverse impact of the virus on sleep apnea patients led to a rise in the demand for and production of sleep apnea devices, such as PAP devices, masks, and sleep ventilators. Lockdowns in nations across the globe increased the adoption of home sleep apnea tests (HSATs) over PSG devices. Telemedicine and teleconsultations also gained popularity during the pandemic, which further supported the growth of the market. However, with the launch of various COVID-19 vaccines, it can be expected that the incidence of COVID-19 will decline gradually, and the market will continue to grow at a normal pace in the coming five years.

Global Sleep Apnea Devices Market Dynamics

DRIVER: Large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market/

The massive pool of undiagnosed patients of sleep apnea holds tremendous potential for the sleep apnea devices market. It is expected with the ongoing awareness campaigns and efforts, the untouched patients base would be diagnosed and treated for the sleep apnea. The increasing trend of oral appliances and home sleep care for the management of sleep apnea are pushing the growth of the market. Over past few years, there is an increasing number of companies venturing into the sleep apnea market.

RESTRAINT: The high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls

The high expenses of the CPAP machines are burden to the patients of sleep apnea, the expenses of these machines are sparsely covered by Medicare in the US, while other countries don’t cover any cost of CPAP. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy creates a huge hurdle for patients.

OPPORTUNITY: Growing demand for home sleep apnea tests (HSATs), and increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence

People are opting more for the home sleep apnea tests (HSATs) due to their affordability and comfort of sleep apnea management at home. The telemedicine has witnessed a surge in the demand maid the pandemic. The incoming advanced technologies in the domain of sleep apnea devices such as Artificial Intelligence (AI) are also creating more opportunities for the market.

CHALLENGES: Lack of patient compliance

The lack of patient compliance to CPAP therapy is a challenging aspect in the growth of the market. Treatment compliance, especially of the CPAP, has always been an issue with sleep apnea patients. This is mainly due to the lack of affordability and comfort.

Therapeutic devices segment dominated the sleep apnea devices market in 2020.

Based on type, the sleep apnea devices market is segmented into therapeutic and diagnostic devices. Therapeutic devices account for the largest share of the sleep apnea devices market. The largest share of the segment is driven by the expanding pool of diagnosed sleep apnea patients, increasing adoption of sleep apnea therapeutic devices, and the improving reimbursement scenario for these devices.

Sleep laboratories & hospitals account for the largest share of the sleep apnea devices market. The home care settings/individuals’ segment is expected to grow at the fastest pace during the forecast period.

Based on end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of in the sleep apnea devices market in 2020. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR from 2021 to 2026, owing to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

Sleep Apnea Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for sleep apnea devices market in 2020.

The sleep apnea devices market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of North American can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and the of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

Key Market Players

The prominent players operating in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Type, End User and Region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare (New Zealand), Inspire Medical Systems, Inc. (US), Lφwenstein Medical Technology GmbH + Co. K.G. (Germany), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Nihon Kohden (Japan), Natus Medical (US), Itamar Medical (Israel), Whole You, Inc. (US), Drive DeVilbiss Healthcare (US), BMC Medical Co. Ltd. (China), BRAEBON Medical (Canada), Invacare Homecare (US), Nidek Medical India (India), Curative Medical (US), LivaNova (UK) Panthera Dental (Canada), and Myerson LLC (US).

This report categorizes the sleep apnea devices market into the following segments and subsegments:

By Type

  • Therapeutic Devices
    • Positive Airway Pressure Devices
      • Automatic Positive Airway Pressure Devices
      • Continuous Positive Airway Pressure Devices
      • Bilevel Positive Airway Pressure Devices
    • Facial Interfaces
      • Masks
        • Full-Face Masks
        • Nasal Pillow Masks
        • Nasal Masks
      • Cushions
    • Accessories
    • Oral Appliances
      • Mandibular Advancement Devices
      • Tongue-Retaining Devices
    • Adaptive Servo-Ventilators
    • Other Therapeutic Devices
  • Diagnostic Devices
    • Polysomnography Devices
      • Ambulatory PSG Devices
      • Clinical PSG Devices
    • Home Sleep Testing Devices
    • Oximeters
      • Fingertip Oximeters
      • Handheld Oximeters
      • Wrist-Worn Oximeters
      • Tabletop Oximeters
    • Actigraphy Systems
    • Sleep Screening Devices

By End User

  • Sleep Laboratories & Hospitals
  • Home Care Settings/Individuals

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

Recent Developments

  • In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to provide Oventus’ obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers via sleep clinics in the US.
  • In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.
  • In November 2020, Panthera Dental collaborated with Dentsply Sirona.
  • In December 2019, Fisher & Paykel Healthcare signed a USD-1.5-million partnership agreement with Counties Manukau Health (CM Health) to provide funding for clinical research at Middlemore Hospital.
  • In March 2019, ResMed acquired HB Healthcare, a home medical equipment provider, which offers sleep and respiratory care devices.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 38)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SEGMENTATION
           1.3.1 MARKETS COVERED
                    FIGURE 1 SLEEP APNEA DEVICES MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
           TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH DATA
           FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 5 SLEEP APNEA DEVICES MARKET – REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED
           FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF SLEEP APNEA DEVICES
           FIGURE 7 CAGR PROJECTIONS
           FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           2.3.1 SECONDARY DATA
           2.3.2 PRIMARY DATA
                    FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
           2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.7 LIMITATIONS
    2.8 RISK ASSESSMENT
           TABLE 3 RISK ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY (Page No. - 62)
    FIGURE 12 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    FIGURE 13 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    FIGURE 14 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET

4 PREMIUM INSIGHTS (Page No. - 67)
    4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
           FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE THE MARKET FOR SLEEP APNEA DEVICES
    4.2 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE (2020)
           FIGURE 18 THERAPEUTIC DEVICES WILL CONTINUE TO DOMINATE THE ASIA PACIFIC SLEEP APNEA DEVICES MARKET IN 2020
    4.3 SLEEP APNEA DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
    4.4 SLEEP APNEA DEVICES MARKET, BY REGION (2019–2026)
           FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE SLEEP APNEA DEVICES MARKET DURING THE FORECAST PERIOD
    4.5 SLEEP APNEA DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS
           FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 71)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           TABLE 4 MARKET DYNAMICS: SLEEP APNEA DEVICES MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Large pool of undiagnosed sleep apnea patients
                               TABLE 5 GLOBAL PREVALENCE OF SLEEP APNEA IN 2019
                               TABLE 6 PREVALENCE OF SLEEP APNEA IN EUROPEAN COUNTRIES
                    5.2.1.2 Favorable reimbursements and financial aid for sleep apnea devices and therapies
                               TABLE 7 REIMBURSEMENT CODES AND COSTS OF SOME SLEEP APNEA DEVICES BY RESMED
                               TABLE 8 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL
                    5.2.1.3 Growing awareness about the ill effects of untreated sleep apnea
                               TABLE 9 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA
                    5.2.1.4 Growing usage of oral appliances
                               TABLE 10 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR THE TREATMENT OF SLEEP APNEA
                    5.2.1.5 Increasing number of companies venturing into the sleep apnea devices and oral appliances markets
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of CPAP machines
                    5.2.2.2 Complex referral pathways, long waiting periods, and product recalls
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for home sleep apnea tests (HSATs)
                    5.2.3.2 Increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of patient compliance
    5.3 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET
           FIGURE 22 COVID-19 IMPACT ON IN-FACILITY PATIENTS OF SLEEP APNEA
           FIGURE 23 SLEEP CARE DELIVERY DURING COVID-19
           FIGURE 24 SLEEP TESTING DURING THE COVID-19
           TABLE 11 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET
           FIGURE 25 COVID-19 IMPACT ON THE REVENUES OF KEY PLAYERS’ SLEEP APNEA DEVICE BUSINESSES
    5.4 REGULATORY ANALYSIS
           TABLE 12 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE SLEEP APNEA DEVICES MARKET
           5.4.1 NORTH AMERICA
                    5.4.1.1 US
                               TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
                               TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.4.1.2 Canada
                               TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.4.2 EUROPE
                    FIGURE 27 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
           5.4.3 ASIA PACIFIC
                    5.4.3.1 Japan
                               5.4.3.1.1 Revision of the Pharmaceutical Affairs Law (PAL) and implementation of the new PMD Act in Japan
                               TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.4.3.2 China
                               TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.4.3.3 India
                    5.4.3.4 Australia
                               5.4.3.4.1 TGA device classification
    5.5 TECHNOLOGY ANALYSIS
           TABLE 18 RECENT TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES
    5.6 PRICING ANALYSIS
           TABLE 19 AVERAGE SELLING PRICES OF POSITIVE AIRWAY PRESSURE DEVICES
           TABLE 20 AVERAGE SELLING PRICES OF FACIAL INTERFACES
           TABLE 21 COST OF SLEEP APNEA TESTING
    5.7 TRADE ANALYSIS
           5.7.1 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016–2020 (USD MILLION)
           5.7.2 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016–2020 (USD MILLION)
    5.8 PATENT ANALYSIS
           FIGURE 28 LIST OF MAJOR PATENTS FOR SLEEP APNEA DEVICES
           FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED FOR THE SLEEP APNEA DEVICES MARKET, 2015–2021
           TABLE 22 INDICATIVE LIST OF SLEEP APNEA DEVICE PATENTS
    5.9 VALUE CHAIN ANALYSIS
           FIGURE 30 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
    5.10 SUPPLY CHAIN ANALYSIS
           FIGURE 31 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.11 ECOSYSTEM ANALYSIS
                    FIGURE 32 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS
           5.11.1 ROLE IN THE ECOSYSTEM
                    FIGURE 33 KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET ECOSYSTEM
    5.12 PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT FROM NEW ENTRANTS
           5.12.2 BARGAINING POWER OF SUPPLIERS
           5.12.3 BARGAINING POWER OF BUYERS
           5.12.4 INTENSITY OF COMPETITIVE RIVALRY
           5.12.5 THREAT FROM SUBSTITUTES
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA DEVICE MANUFACTURERS
           5.13.2 REVENUE SHIFT FOR SLEEP APNEA DEVICES
    5.14 RANGES/SCENARIOS
           5.14.1 PESSIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET
           5.14.2 REALISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET
           5.14.3 OPTIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET

6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA (Page No. - 117)
    6.1 INTRODUCTION
    6.2 EPIDEMIOLOGICAL ASSESSMENT
           FIGURE 34 TOP TEN COUNTRIES WITH THE HIGHEST ESTIMATED NUMBER OF INDIVIDUALS WITH OBSTRUCTIVE SLEEP APNOEA BASED ON THE AMERICAN ACADEMY OF SLEEP MEDICINE 2012 CRITERIA
    6.3 PRESCRIPTION PATTERN ASSESSMENT
    6.4 ADHERENCE ASSESSMENT

7 ALTERNATE THERAPIES FOR SLEEP APNEA (Page No. - 122)
    7.1 INTRODUCTION
    7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE
    7.3 HYPOGLOSSAL NERVE STIMULATION
    7.4 ORAL PRESSURE THERAPY (OPT)
    7.5 POSITIONAL THERAPY

8 SLEEP APNEA DEVICES MARKET, BY TYPE (Page No. - 125)
    8.1 INTRODUCTION
           TABLE 23 SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
    8.2 THERAPEUTIC DEVICES
           TABLE 24 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 25 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.1 POSITIVE AIRWAY PRESSURE DEVICES
                    TABLE 26 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 27 PAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.1.1 Continuous positive airway pressure devices
                               8.2.1.1.1 CPAP devices are considered the gold standard in sleep apnea treatment—a key factor driving market growth
                               TABLE 28 CPAP DEVICES OFFERED BY KEY PLAYERS
                               TABLE 29 CPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.1.2 Automatic positive airway pressure devices
                               8.2.1.2.1 Demand for APAP devices has increased significantly in the last few years due to patient non-compliance with CPAP devices
                               TABLE 30 APAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.1.3 Bilevel positive airway pressure devices
                               8.2.1.3.1 BPAP devices are generally costlier and more complex than other available PAP devices, which is a major reason for their low adoption
                               TABLE 31 BPAP DEVICES OFFERED BY KEY PLAYERS
                               TABLE 32 BPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.2 FACIAL INTERFACES
                    TABLE 33 FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 34 FACIAL INTERFACES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.2.1 Masks
                               TABLE 35 MASKS OFFERED BY KEY PLAYERS
                               TABLE 36 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 37 MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               8.2.2.1.1 Full-face masks
                                             8.2.2.1.1.1 Full-face masks offer the greatest chance of compliance for mouth breathers or patients who struggle to breathe through their nose
                               TABLE 38 FULL-FACE MASKS OFFERED BY KEY PLAYERS
                               TABLE 39 FULL-FACE MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               8.2.2.1.2 Nasal pillow masks
                                             8.2.2.1.2.1 Greater patient compliance is one of the key factors driving the demand for nasal pillow masks
                               TABLE 40 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
                               TABLE 41 NASAL PILLOW MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               8.2.2.1.3 Nasal masks
                                             8.2.2.1.3.1 Nasal masks have an advantage over full-face masks in that they do not obstruct the patients’ view and allow patients to wear spectacles
                               TABLE 42 NASAL MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.2.2 Cushions
                               8.2.2.2.1 Different product launches in the past few years to drive market growth
                               TABLE 43 CUSHIONS OFFERED BY KEY PLAYERS
                               TABLE 44 CUSHIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.3 ACCESSORIES
                    TABLE 45 ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 46 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.1 Humidifier accessories
                               8.2.3.1.1 Humidifiers help to open the airways, decrease congestion, and encourage clearer breathing
                               TABLE 47 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.2 Power accessories
                               8.2.3.2.1 Power accessories help to manage uninterrupted sleep apnea therapy in the absence of a power supply
                               TABLE 48 POWER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.3 Transportation accessories
                               8.2.3.3.1 The convenience associated with transportation accessories to drive market growth
                               TABLE 49 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.4 Communication accessories
                               8.2.3.4.1 Communication accessories help monitor sleep apnea symptoms through teleconsultations
                               TABLE 50 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.5 Chin restraints
                               8.2.3.5.1 Chin restraints hold the mouth in position during therapy— an essential part of sleep apnea management
                               TABLE 51 CHIN RESTRAINTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.3.6 Other accessories
                               TABLE 52 OTHER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.4 ORAL APPLIANCES
                    TABLE 53 ORAL APPLIANCES OFFERED BY KEY PLAYERS
                    TABLE 54 ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 55 ORAL APPLIANCES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.4.1 Mandibular advancement devices
                               8.2.4.1.1 Mandibular advancement devices are primarily used for the treatment of mild OSA and snoring
                               TABLE 56 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.2.4.2 Tongue-retaining devices
                               8.2.4.2.1 TRDs are less expensive and help reduce both snoring and sleep apnea
                               TABLE 57 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.5 ADAPTIVE SERVO-VENTILATORS
                    8.2.5.1 Improving clinical outcomes associated with ASVs to fuel market growth
                               TABLE 58 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.2.6 OTHER THERAPEUTIC DEVICES
                    TABLE 59 OTHER THERAPEUTIC DEVICES OFFERED BY THE KEY PLAYERS
                    TABLE 60 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
    8.3 DIAGNOSTIC DEVICES
           TABLE 61 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 62 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.1 POLYSOMNOGRAPHY DEVICES
                    TABLE 63 PSG DEVICES OFFERED BY KEY PLAYERS
                    TABLE 64 PSG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 65 PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.1.1 Ambulatory PSG devices
                               8.3.1.1.1 The demand for ambulatory PSG devices has increased due to their cost-effectiveness and convenience for patients
                               TABLE 66 AMBULATORY PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.1.2 Clinical PSG devices
                               8.3.1.2.1 These devices require constant supervision—a key factor limiting market growth
                               TABLE 67 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS
                               TABLE 68 CLINICAL PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.2 HOME SLEEP TESTING DEVICES
                    8.3.2.1 Cost-effectiveness and comfort of home sleep testing are expected to drive the growth of home sleep testing devices
                               TABLE 69 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.3 OXIMETERS
                    TABLE 70 OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 71 OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.3.1 Fingertip oximeters
                               8.3.3.1.1 A major drawback of fingertip oximeters is that they cannot provide precise readings if the patient’s hand is injured or if there is slow blood flow due to blood clotting or any injury
                               TABLE 72 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
                               TABLE 73 FINGERTIP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.3.2 Handheld oximeters
                               8.3.3.2.1 Handheld oximeters are more expensive than fingertip and wrist oximeters
                               TABLE 74 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
                               TABLE 75 HANDHELD OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.3.3 Wrist-worn oximeters
                               8.3.3.3.1 The global demand for wrist-worn oximeters is propelled by their small size, long-term usage, need for overnight monitoring, and their portability
                               TABLE 76 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
                               TABLE 77 WRIST-WORN OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    8.3.3.4 Tabletop oximeters
                               8.3.3.4.1 Tabletop oximeters account for a smaller share of the market than handheld or wrist-worn oximeters due to their higher cost and fewer applications
                               TABLE 78 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
                               TABLE 79 TABLETOP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.4 ACTIGRAPHY SYSTEMS
                    8.3.4.1 Increasing focus on assessing actimeter performance contributes to market growth
                               TABLE 80 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.5 SLEEP SCREENING DEVICES
                    8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort are driving the use of sleep screening devices
                               TABLE 81 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
                               TABLE 82 SLEEP SCREENING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)

9 SLEEP APNEA DEVICES MARKET, BY END USER (Page No. - 164)
    9.1 INTRODUCTION
           TABLE 83 SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 SLEEP LABORATORIES & HOSPITALS
           9.2.1 ADVANCED INFRASTRUCTURE AND EXPENDITURE OF SLEEP LABORATORIES & HOSPITALS TO DRIVE GROWTH IN THIS END-USER SEGMENT
                    TABLE 84 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES & HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
    9.3 HOME CARE SETTINGS/INDIVIDUALS
           9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH
                    TABLE 85 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2019–2026 (USD MILLION)

10 SLEEP APNEA DEVICES MARKET, BY REGION (Page No. - 169)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
               FIGURE 35 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
               TABLE 86 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
               TABLE 87 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 88 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 89 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 90 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 91 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 92 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 93 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 94 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 95 NORTH AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 96 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 97 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                       10.2.1.1 Availability of grants and funds and the increasing trend of home sleep testing are expected to drive market growth in the US during the forecast period
                                   TABLE 98 KEY SLEEP APNEA PRODUCTS IN THE US
                                   TABLE 99 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 100 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 101 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 102 US: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 103 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 104 US: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 105 US: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 106 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 107 US: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 108 US: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 109 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 Rising number of research grants and health programs to drive market growth in Canada
                                   TABLE 110 KEY SLEEP APNEA PRODUCTS IN CANADA
                                   TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 112 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 113 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 114 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 115 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 116 CANADA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 117 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 118 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 119 CANADA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 120 CANADA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 121 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
               TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
               TABLE 123 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 124 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 125 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 126 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 127 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 128 EUROPE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 129 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 130 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 131 EUROPE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 132 EUROPE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 133 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 Prevalence of OSA in Germany is among the highest in Europe—a key factor driving market growth
                                   TABLE 134 KEY SLEEP APNEA PRODUCTS IN GERMANY
                                   TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 136 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 137 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 138 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 139 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 140 GERMANY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 141 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 142 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 143 GERMANY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 144 GERMANY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 145 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 FRANCE
                       10.3.2.1 Rising geriatric population to increase the incidence of sleep apnea in France
                                   TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 147 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 148 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 149 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 150 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 151 FRANCE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 152 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 153 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 154 FRANCE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 155 FRANCE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 156 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 UK
                       10.3.3.1 Rising awareness initiatives and sleep service groups to support market growth in the UK
                                   TABLE 157 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 158 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 159 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 160 UK: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 161 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 162 UK: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 163 UK: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 164 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 165 UK: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 166 UK: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 167 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                       10.3.4.1 High prevalence of sleep apnea and increasing awareness to drive market growth in Italy
                                   TABLE 168 PREVALENCE OF OBSTRUCTIVE SLEEP APNEA FOR THE POPULATION IN ITALY, 2018
                                   TABLE 169 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 170 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 171 ITALY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 172 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 173 ITALY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 174 ITALY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 175 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 176 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 177 ITALY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 178 ITALY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 179 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                       10.3.5.1 Increasing initiatives for awareness by regional organizations are driving the market growth in Spain
                                   TABLE 180 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 181 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 182 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 183 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 184 SPAIN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 185 SPAIN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 186 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 187 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 188 SPAIN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 189 SPAIN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 190 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 191 ROE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 192 ROE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 193 ROE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 194 ROE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 195 ROE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 196 ROE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 197 ROE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 198 ROE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 199 ROE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 200 ROE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 201 ROE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
               FIGURE 36 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
               TABLE 202 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
               TABLE 203 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 204 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 205 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 206 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 207 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 208 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 209 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 210 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 211 ASIA PACIFIC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 212 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 213 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                       10.4.1.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to drive market growth in Japan
                                   TABLE 214 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 215 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 216 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 217 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 218 JAPAN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 219 JAPAN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 220 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 221 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 222 JAPAN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 223 JAPAN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 224 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 CHINA
                       10.4.2.1 Growing adult obesity rates and expanding geriatric population to increase the prevalence of sleep apnea in China
                                   TABLE 225 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 226 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 227 CHINA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 228 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 229 CHINA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 230 CHINA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 231 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 232 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 233 CHINA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 234 CHINA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 235 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 AUSTRALIA
                       10.4.3.1 High prevalence of sleep apnea and growing number of awareness programs to drive market growth in Australia
                                   TABLE 236 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 237 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 238 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 239 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 240 AUSTRALIA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 241 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 242 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 243 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 244 AUSTRALIA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 245 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 246 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 247 ROAPAC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 248 ROAPAC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 249 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 250 ROAPAC: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 251 ROAPAC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 252 ROAPAC: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 253 ROAPAC: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 254 ROAPAC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 255 ROAPAC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 256 ROAPAC: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 257 ROAPAC: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 REST OF THE WORLD
               TABLE 258 ROW: SLEEP APNEA DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
               TABLE 259 ROW: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 260 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 261 ROW: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 262 ROW: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 263 ROW: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 264 ROW: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 265 ROW: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 266 ROW: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
               TABLE 267 ROW: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 268 ROW: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 269 ROW: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.1 LATIN AMERICA
                       10.5.1.1 Increasing obesity rate in latam has resulted in increased prevalence of sleep apnea
                                   TABLE 270 LATAM: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 271 LATAM: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 272 LATAM: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 273 LATAM: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 274 LATAM: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 275 LATAM: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 276 LATAM: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 277 LATAM: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 278 LATAM: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 279 LATAM: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 280 LATAM: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.2 MIDDLE EAST & AFRICA
                       10.5.2.1 Dearth of awareness about sleep apnea restrains market growth in the Middle East & Africa
                                   TABLE 281 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 282 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 283 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 284 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 285 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 286 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 287 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 288 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                   TABLE 289 MIDDLE EAST & AFRICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 290 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 291 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 255)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             11.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET
     11.3 REVENUE ANALYSIS
               FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET
     11.4 MARKET SHARE ANALYSIS
               FIGURE 38 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, 2020
               TABLE 292 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
             11.5.1 STARS
             11.5.2 PERVASIVE PLAYERS
             11.5.3 EMERGING LEADERS
             11.5.4 PARTICIPANTS
                       FIGURE 39 SLEEP APNEA DEVICES MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2020
     11.6 COMPANY EVALUATION QUADRANT (SMES/STARTUPS)
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                       FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     11.7 COMPETITIVE BENCHMARKING
             11.7.1 COMPANY PRODUCT FOOTPRINT (21 COMPANIES)
             11.7.2 COMPANY REGIONAL FOOTPRINT
             11.7.3 COMPANY FOOTPRINT
     11.8 COMPETITIVE SCENARIO AND TRENDS
             11.8.1 PRODUCT LAUNCHES & APPROVALS
                       TABLE 293 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–JULY 2021
             11.8.2 DEALS
                       TABLE 294 DEALS, JANUARY 2018–JULY 2021
             11.8.3 OTHER DEVELOPMENTS
                       TABLE 295 OTHER DEVELOPMENTS, JANUARY 2018–JULY 2021

12 COMPANY PROFILES (Page No. - 270)
     12.1 KEY PLAYERS
(Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
             12.1.1 RESMED
                       TABLE 296 RESMED: BUSINESS OVERVIEW
                       FIGURE 41 RESMED: COMPANY SNAPSHOT (2020)
             12.1.2 KONINKLIJKE PHILIPS N.V.
                       TABLE 297 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                       FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
             12.1.3 FISHER & PAYKEL HEALTHCARE
                       TABLE 298 FISHER & PAYKEL HEALTHCARE: BUSINESS OVERVIEW
                       FIGURE 43 FISHER & PAYKEL HEALTHCARE: COMPANY SNAPSHOT (2020)
             12.1.4 INSPIRE MEDICAL SYSTEMS, INC.
                       TABLE 299 INSPIRE MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
                       FIGURE 44 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
             12.1.5 SOMNOMED
                       TABLE 300 SOMNOMED: BUSINESS OVERVIEW
                       FIGURE 45 SOMNOMED: COMPANY SNAPSHOT (2020)
             12.1.6 OVENTUS MEDICAL
                       TABLE 301 OVENTUS MEDICAL: BUSINESS OVERVIEW
                       FIGURE 46 OVENTUS MEDICAL: COMPANY SNAPSHOT (2020)
             12.1.7 COMPUMEDICS
                       TABLE 302 COMPUMEDICS: BUSINESS OVERVIEW
                       FIGURE 47 COMPUMEDICS: COMPANY SNAPSHOT (2020)
             12.1.8 LΦWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.
                       TABLE 303 LΦWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.: BUSINESS OVERVIEW
             12.1.9 DRIVE DEVILBISS HEALTHCARE
                       TABLE 304 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW
             12.1.10 BMC MEDICAL CO., LTD.
                       TABLE 305 BMC MEDICAL CO., LTD.: BUSINESS OVERVIEW
             12.1.11 BRAEBON MEDICAL CORPORATION
                       TABLE 306 BRAEBON MEDICAL CORPORATION: BUSINESS OVERVIEW
             12.1.12 WHOLE YOU, INC.
                       TABLE 307 WHOLE YOU, INC.: BUSINESS OVERVIEW
             12.1.13 PANTHERA DENTAL
                       TABLE 308 PANTHERA DENTAL: BUSINESS OVERVIEW
             12.1.14 MYERSON LLC
                       TABLE 309 MYERSON LLC: BUSINESS OVERVIEW
*Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS
             12.2.1 NIDEK MEDICAL INDIA
                       TABLE 310 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
             12.2.2 CURATIVE MEDICAL
                       TABLE 311 CURATIVE MEDICAL: COMPANY OVERVIEW
             12.2.3 LIVANOVA
                       TABLE 312 LIVANOVA: COMPANY OVERVIEW
             12.2.4 INVACARE CORPORATION
                       TABLE 313 INVACARE CORPORATION: COMPANY OVERVIEW
             12.2.5 ITAMAR MEDICAL LTD.
                       TABLE 314 ITAMAR MEDICAL LTD.: COMPANY OVERVIEW
             12.2.6 NIHON KOHDEN
                       TABLE 315 NIHON KOHDEN: COMPANY OVERVIEW
             12.2.7 NATUS MEDICAL INCORPORATED
                       TABLE 316 NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW

13 APPENDIX (Page No. - 317)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the sleep apnea devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the sleep apnea devices market. The secondary sources used for this study include American Academy of Sleep Medicine (AASM), American Association of Sleep Technologists (AAST), American Sleep Apnea Association (ASAA), American Board of Dental Sleep Medicine (ABDSM), National Center for Biotechnology Information (NCBI), National Institute for Health and Care Excellence (NICE), National Institutes of Health (NIH), Canadian Sleep Society (CSS), Canadian Society of Respiratory Therapists (CSRT), Canadian Sleep & Circadian Network, and British Lung Foundation (BLF). The data sources for Europe included the European Sleep Research Society (ESRS). For the Asia Pacific region, Sleep Diagnosis and Therapy (China), Global Times (China), Australasian Sleep Association (ASA), and SNORE Australia, Annual Reports, SEC Filings, Investor Presentations, and Press Releases of Key Players, White Papers, Journals/Magazines, and News Articles SEC Filings, Annual Reports, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Sleep Apnea Devices Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the sleep apnea devices business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global sleep apnea devices market based on the type, end user and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
  • To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To strategically profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies
  • To track and analyse competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the sleep apnea devices market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional eight company profiles
COVID-19

Get in-depth analysis of the COVID-19 impact on the Sleep Apnea Devices Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Sleep Apnea Devices Market

Request For Special Pricing
Report Code
MD 1181
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sleep Apnea Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved